At ARC, we're passionate about supporting the advancement of high quality biomarker testing in precision medicine research and the full service research outsourcing for in vitro diagnostic (IVD) medical device validation.
Our work on more than 30 precision medicine and IVD programmes across oncology, auto immune and cardiac therapy biomarkers has helped to deliver high-quality, robust clinical data to expedite successful regulatory submissions and global market launches.
We see a future where patient care is kind, available and precise; where all global citizens benefit from the promise of next generation technologies and therapies. Come and join the ARC revolution and apply to our team today.
Article written by ARC Insights
ARC Insights offers a mix of industry specific content with the aim to keep its readers informed, educated, and up to date with the latest developments, trends, and expert knowledge in the FiH translational medicine space.
